Advertisement

Topics

Vector Capital Company Profile

16:21 EDT 23rd September 2018 | BioPortfolio

Vector Capital is a leading global private equity firm specializing in transformational investments in established technology businesses. Vector identifies and pursues these complex investments in both the private and public markets. Vector actively partners with management teams to devise and execute new financial and business strategies that materially improve the competitive standing of these businesses and enhance their value for employees, customers and shareholders. Among Vector's notable investments are 20-20 Technologies, Aladdin Knowledge Systems, Cambium Networks, Corel, Gerber Scientific, RAE Systems, LANDesk Software, Register.com, SafeNet, Technicolor, Teletrac, Tidel, WatchGuard Technologies, and WinZip.


News Articles [666 Associated News Articles listed on BioPortfolio]

GE creates ready-to-run factory for viral vector drugs

GE Healthcare has created a ‘factory-in-a-box’ facility for the production of viral vector-based drugs, including viral vector vaccines, oncolytic viruses,...Read More... The post GE creat...

[Comment] Measuring the effect of insecticide resistance: are we making progress?

Exceptional global efforts to fight malaria have greatly reduced the disease burden by more than 500 million cases since 2000 in sub-Saharan Africa.1 These gains are partly ascribed to vector control ...

#jobs #lifescience Paramount Recruitment: Viral Vector Scientist – AAV- Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Viral Vector Scientist – AAV- Oxford . Negotiabl...

#jobs #lifescience Paramount Recruitment: Viral Vector Engineering Scientist – Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Viral Vector Engineering Scientist – Oxford . Ne...

#jobs #lifescience Paramount Recruitment: Viral Vector Scientist- Lentiviral – Oxford

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Viral Vector Scientist- Lentiviral – Oxford . Ne...

HP/Agilent 4193A Vector Impedance Meter 0.4 to 110MHz  Probe Only

$750.00End Date: Thursday May-10-2018 21:42:11 PDTBuy It Now for only: $750.00Buy It Now | Add to watch list Biotech365 : HP/Agilent 4193A Vector Impedance Meter 0.4 to 110MHz  Probe Only BioMar...

GE accelerates production of viral vector based therapeutics

GE Healthcare has launched a new factory-in-a-box, designed to accelerate the manufacture of products requiring a biosafety level 2 environment such as viral vector-based therapeutics

Sartorius supports ABL Europe to expand viral vector GMP capacity

A global technology player in the biopharma industry supports a supplier of viral vector manufacturing services to successfully complete a capacity expansion

PubMed Articles [540 Associated PubMed Articles listed on BioPortfolio]

What is the association between social capital and diabetes mellitus? A systematic review.

Social capital has been included as an element that could influence the self-perception of health, mortality and mental diseases. We systematically reviewed papers that studied the influence of social...

"Who'll do all these if I'm not around?": Bonding social capital and health and well-being of inpatients.

Although social capital influences health-related decisions and behavioural patterns in many developing countries, minimal attention has been paid to the nuances of its effect on healthcare. This pape...

Association Between Community Social Capital and Hospital Readmission Rates.

Hospital readmissions remain frequent, and are partly attributable to patients' social needs. The authors sought to examine whether local community levels of social capital are associated with hospita...

Social Capital, Community Capacity, and Health.

The capacity to practice health behavior is different for each individual. Community capacity and social capital deal with understanding the relationship between community members and with the factors...

Is community social capital associated with subjective symptoms of dementia among older people? A cross-sectional study in Japan.

Many studies have reported the preventive effects of community social capital on health outcomes, such as mortality and incidence of diseases. However, evidence on the association between community so...

Clinical Trials [269 Associated Clinical Trials listed on BioPortfolio]

Social Capital and Engagement in Care Among Young Black Men Who Have Sex With Men Living With HIV

The study is a randomized controlled trial to evaluate the social capital intervention versus a general health promotion intervention (Health for Life; H4L) among groups of Young black men...

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis

OBJECTIVES: I. Determine the maximum tolerated dose of recombinant adeno-associated virus-CFTR vector in patients with cystic fibrosis. II. Assess the safety of this gene therap...

Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

The 13G01 clinical trial is a Phase I/II dose escalation study designed to be conducted in adults with inflammatory arthritis who have persistent moderate or severe swelling in one or more...

Implementation Research of New Dengue Vector Control Tools

This project will provide new insights concerning how to reduce dengue transmission by means of cost-effective and sustainable implementation strategies of vector control methods. The res...

Companies [1129 Associated Companies listed on BioPortfolio]

Vector Capital

Vector Capital is a leading global private equity firm specializing in transformational investments in established technology businesses. Vector identifies and pursues these compl...

Bavarian Nordic A/S

In 2004 we marked our 10 year anniversary as a company. Over the past decade we have developed the early MVA vector research into a broad commercial vaccine vector technology.

SIRION Biotech GmbH

Founded in 2005, SIRION Biotech is a global leader in developing research and commercial grade viral vector solutions for industry and academic partners who are developing gene th...

Genethon

Genethon produces recombinant viral vectors for gene transfer. The vectors can be used for research or preclinical studies. GMP grade vector preparations will be available in the near future.We can ei...

Cynvec LLC

Cynvec, a privately held biotechnology company, is developing proprietary cancer therapies based on the apoptotic sindbis oncolytic viral vector, a novel technology that targets the over expressed lam...

More Information about "Vector Capital" on BioPortfolio

We have published hundreds of Vector Capital news stories on BioPortfolio along with dozens of Vector Capital Clinical Trials and PubMed Articles about Vector Capital for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vector Capital Companies in our database. You can also find out about relevant Vector Capital Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record